CLINICAL_TRIALS
trial_result
· 2021-05-10
Clinical Trial Update: Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children [Phase 3]
Summary
A Phase 3 trial completed evaluating dasiglucagon for treating hypoglycemia in children with type 1 diabetes; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zealand Pharma | Conditions: Hypoglycemia | Phase 3 | Status: COMPLETED | Results posted: 2021-05-10